These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5992067)

  • 1. [On the action of propranolol on the phases of cardiac dynamics in normal, myocardiosclerotic and hypersympathicotonic subjects].
    Lixi M; Camoglio E; Sassu P; Biddau C; Porrazzo G; Raffo M; Cherchi A
    Boll Soc Ital Cardiol; 1966; 11(4):1510-22. PubMed ID: 5992067
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of propranolol in essential circulatory hyperkinesis.
    Török E; Matos L; Rausch J; Simonyi J
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):246-52. PubMed ID: 4902019
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of various hemodynamic effects induced by adrenergic-beta block].
    Delgrossi S; Matteoli E
    Cuore Circ; 1968 Apr; 52(2):92-100. PubMed ID: 4245299
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of beta adrenergic blockade on the cardiovascular system in the state of sympathicotonia in children].
    Baszczyński J
    Pediatr Pol; 1968; 44(1):47-52. PubMed ID: 5728842
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical applications of inhibition of beta-adrenergic receptors with propranolol.
    Stampfer M; Epstein SE
    J Med Assoc Ga; 1969 May; 58(5):197-8. PubMed ID: 5772208
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relationship between the activity of sympathico-adrenal system and clinico-physiological parameters in patients with ischemic heart disease during inderal therapy].
    Orlov VN; Chigrinova LS
    Ter Arkh; 1982; 54(5):53-7. PubMed ID: 7115506
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of verapamil on the dynamics of heart conduction].
    Amino JG; Studart PC; de Brito AH; Brando PR; Maia IG; Almeida G; Dohmann HJ
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():37-41. PubMed ID: 889473
    [No Abstract]   [Full Text] [Related]  

  • 8. [Propranolol--a place in the modern therapy].
    Olakowska E; Olakowski M
    Wiad Lek; 2006; 59(5-6):388-91. PubMed ID: 17017488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of the sympathetic nervous system in functional cardiac disorders and the action of beta-adrenergic sympathetic blocking agents].
    Lichtig E; Georgescu M; Păun R
    Med Interna (Bucur); 1968 Feb; 20(2):163-74. PubMed ID: 5668963
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary cardiac hyperkinetic syndrome: diagnosis and therapy].
    Bartorelli C; Guazzi M
    Riv Med Aeronaut Spaz; 1974; 37(3-4):261-79. PubMed ID: 4470230
    [No Abstract]   [Full Text] [Related]  

  • 11. [Polycardiographic study of the effect of propranolol and isoproterenol in normal subjects and coronary disease patients].
    Vitolo E; Bruno L; Bellinvia P; Rizzato GF
    Cuore Circ; 1970 Feb; 54(1):1-22. PubMed ID: 5421357
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe sympathetic hyperactivity associated with tetanus.
    Kanarek DJ; Kaufman B; Zwi S
    Arch Intern Med; 1973 Oct; 132(4):602-4. PubMed ID: 4742412
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy in the use of beta-adrenergic blockaders in the treatment of thyrotoxic disorders of the heart].
    Smolenskiĭ VS; Rom-Boguslavskaia ES; Abinder AA; Levchenko TP
    Probl Endokrinol (Mosk); 1973; 19(6):20-5. PubMed ID: 4148862
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of beta adrenergic blockaders on repolarization phase abnormalities in electrocardiography of patients with organic heart disease].
    Wrabec K; Lukasik S; Nowosad H; Adamus J
    Pol Tyg Lek; 1974 Jul; 29(26):1109-11. PubMed ID: 4848571
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined use of isoproterenol and propranolol in cardiogenic shock.
    Stubbs D; Pugh D; Bell H
    Clin Pharmacol Ther; 1970; 11(2):244-50. PubMed ID: 5416854
    [No Abstract]   [Full Text] [Related]  

  • 16. [Propranolol, pharmacological considerations and clinical use].
    Meciani L; Ricci G; Sabatini G; Boeri S; Pirovano E
    Minerva Cardioangiol; 1969 Oct; 17(10):730-54. PubMed ID: 5404966
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of anaprilin on cardiac hemodynamic indices in elderly hypertensive patients].
    Severova NL
    Vrach Delo; 1983 May; (5):26-30. PubMed ID: 6136127
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of obzidan on the indices of gas exchange and the sympathetic-adrenal system in ischemic heart disease patients with different types of circulation].
    Katsenovich RA; Kostko SZ; Kozhinskiĭ VM; Kuchenkova MA
    Ter Arkh; 1984; 56(9):51-3. PubMed ID: 6515548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of glucagon on hemodynamics of the human heart following beta-receptor blockade].
    Avenhaus H; Lüderitz B; Nordeck E
    Verh Dtsch Ges Kreislaufforsch; 1971; 37():427-32. PubMed ID: 5141016
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the effect of propranolol on the effort electrocardiogram in normal, hypersympathotonic, coronary and pericarditis patients].
    Cherchi A; Lixi M; Raffo M; Porrazzo G; Bina M; Camoglio E; Verona F
    Boll Soc Ital Cardiol; 1967; 12(6):587-97. PubMed ID: 5608615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.